New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
A new toolkit to engineer safe and efficient therapeutic cells

A new toolkit to engineer safe and efficient therapeutic cells

by Stacie Dodgson and Françoise Chanut,Gladstone InstitutesGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.03.023Therapies based on engineered immune cells have recen
Immunology & Rheumatology May 07,2024
A new toolkit to engineer safe and efficient therapeutic cells

A new toolkit to engineer safe and efficient therapeutic cells

by Stacie Dodgson and Françoise Chanut,Gladstone InstitutesGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.03.023Therapies based on engineered immune cells have recen
Immunology & Rheumatology May 07,2024
Dietary fiber in the gut may help with skin allergies, says new study

Dietary fiber in the gut may help with skin allergies, says new study

by Monash UniversityCredit: Unsplash/CC0 Public DomainA Monash University study exploring the emerging gut-skin axis has found that microbial fermentation of dietary fiber in the gut can protect
Immunology & Rheumatology May 07,2024
Dietary fiber in the gut may help with skin allergies, says new study

Dietary fiber in the gut may help with skin allergies, says new study

by Monash UniversityCredit: Unsplash/CC0 Public DomainA Monash University study exploring the emerging gut-skin axis has found that microbial fermentation of dietary fiber in the gut can protect
Immunology & Rheumatology May 07,2024
A small T cell switch with a big impact

A small T cell switch with a big impact

by Julius-Maximilians-Universität WürzburgCredit: CC0 Public DomainT cells play a key role in the human immune system. They are capable of distinguishing diseased or foreign tissue from the body&
Immunology & Rheumatology May 07,2024
A small T cell switch with a big impact

A small T cell switch with a big impact

by Julius-Maximilians-Universität WürzburgCredit: CC0 Public DomainT cells play a key role in the human immune system. They are capable of distinguishing diseased or foreign tissue from the body&
Immunology & Rheumatology May 07,2024
T cell behavior determines which tumors respond to treatment

T cell behavior determines which tumors respond to treatment

by Weill Cornell Medical CollegeCredit: CC0 Public DomainImmunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn't work, and ne
Oncology May 07,2024
T cell behavior determines which tumors respond to treatment

T cell behavior determines which tumors respond to treatment

by Weill Cornell Medical CollegeCredit: CC0 Public DomainImmunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn't work, and ne
Oncology May 07,2024
Right-sided colon cancer patients have poorer survival than those with left-sided disease

Right-sided colon cancer patients have poorer survival than those with left-sided disease

by American College of SurgeonsKiller T cells surround a cancer cell. Credit: NIHORLANDO (July 23, 2018): Patients with colorectal cancer tumors on the right side may have poorer five-year surviv
Oncology May 07,2024
Right-sided colon cancer patients have poorer survival than those with left-sided disease

Right-sided colon cancer patients have poorer survival than those with left-sided disease

by American College of SurgeonsKiller T cells surround a cancer cell. Credit: NIHORLANDO (July 23, 2018): Patients with colorectal cancer tumors on the right side may have poorer five-year surviv
Oncology May 07,2024
One test to diagnose them all: Researchers exploit cancers' unique DNA signature

One test to diagnose them all: Researchers exploit cancers' unique DNA signature

by Abu Sina, Laura G. Carrascosa And Matt Trau,The ConversationCredit: AI-generated imageResearchers have developed a test that could be used to diagnose all cancers. It is based on a unique DNA
Oncology May 07,2024
One test to diagnose them all: Researchers exploit cancers' unique DNA signature

One test to diagnose them all: Researchers exploit cancers' unique DNA signature

by Abu Sina, Laura G. Carrascosa And Matt Trau,The ConversationCredit: AI-generated imageResearchers have developed a test that could be used to diagnose all cancers. It is based on a unique DNA
Oncology May 07,2024
Targeted treatment could prevent spread of pancreatic cancer, heart damage

Targeted treatment could prevent spread of pancreatic cancer, heart damage

by Katie Pence,University of Cincinnati Academic Health CenterPancreatic cancer cells, under a microscope. Credit: University of CincinnatiResearchers at the University of Cincinnati (UC) Colleg
Oncology May 07,2024
Targeted treatment could prevent spread of pancreatic cancer, heart damage

Targeted treatment could prevent spread of pancreatic cancer, heart damage

by Katie Pence,University of Cincinnati Academic Health CenterPancreatic cancer cells, under a microscope. Credit: University of CincinnatiResearchers at the University of Cincinnati (UC) Colleg
Oncology May 07,2024
Promising new pancreatic cancer treatment moves forward

Promising new pancreatic cancer treatment moves forward

by Huntsman Cancer InstituteCredit: CC0 Public DomainEven among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progres
Oncology May 07,2024
Promising new pancreatic cancer treatment moves forward

Promising new pancreatic cancer treatment moves forward

by Huntsman Cancer InstituteCredit: CC0 Public DomainEven among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progres
Oncology May 07,2024
Immune response to HIV virus linked to cancer mutations

Immune response to HIV virus linked to cancer mutations

by Federica Giannelli,University of SaskatchewanMadison Adolph and Linda Chelico (left) uncovered how enzymes in the immune system may “go rogue” and cause cancer. Credit: David Stobbe"Our
Oncology May 07,2024
Immune response to HIV virus linked to cancer mutations

Immune response to HIV virus linked to cancer mutations

by Federica Giannelli,University of SaskatchewanMadison Adolph and Linda Chelico (left) uncovered how enzymes in the immune system may “go rogue” and cause cancer. Credit: David Stobbe"Our
Oncology May 07,2024
Greater prevalence of anal cancer precursors for women living with HIV than prior reports

Greater prevalence of anal cancer precursors for women living with HIV than prior reports

by Boston Medical CenterCredit: CC0 Public DomainThe prevalence of anal high-grade squamous intraepithelial lesions (HSIL), which precede anal cancer, is much higher in women living with HIV than
Oncology May 07,2024
Greater prevalence of anal cancer precursors for women living with HIV than prior reports

Greater prevalence of anal cancer precursors for women living with HIV than prior reports

by Boston Medical CenterCredit: CC0 Public DomainThe prevalence of anal high-grade squamous intraepithelial lesions (HSIL), which precede anal cancer, is much higher in women living with HIV than
Oncology May 07,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com